281 related articles for article (PubMed ID: 2447164)
1. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH
J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.
Kaushal DC; Carter R; Rener J; Grotendorst CA; Miller LH; Howard RJ
J Immunol; 1983 Nov; 131(5):2557-62. PubMed ID: 6631012
[TBL] [Abstract][Full Text] [Related]
3. Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates.
Premawansa S; Peiris JS; Perera KL; Ariyaratne G; Carter R; Mendis KN
J Immunol; 1990 Jun; 144(11):4376-83. PubMed ID: 1692862
[TBL] [Abstract][Full Text] [Related]
4. Immunity to sexual stages of human malaria parasites: immune modulation during natural infections, antigenic determinants, and the induction of transmission-blocking immunity.
Targett G
Scand J Infect Dis Suppl; 1990; 76():79-88. PubMed ID: 1714627
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes.
Vermeulen AN; Roeffen WF; Henderik JB; Ponnudurai T; Beckers PJ; Meuwissen JH
Dev Biol Stand; 1985; 62():91-7. PubMed ID: 2422080
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.
Bull World Health Organ; 1984; 62(5):715-27. PubMed ID: 6391715
[TBL] [Abstract][Full Text] [Related]
9. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.
Read D; Lensen AH; Begarnie S; Haley S; Raza A; Carter R
Parasite Immunol; 1994 Oct; 16(10):511-9. PubMed ID: 7532850
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
[TBL] [Abstract][Full Text] [Related]
11. Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors.
Good MF; Quakyi IA; Saul A; Berzofsky JA; Carter R; Miller LH
J Immunol; 1987 Jan; 138(1):306-11. PubMed ID: 2431058
[TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
13. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies.
Carter R; Graves PM; Quakyi IA; Good MF
J Exp Med; 1989 Jan; 169(1):135-47. PubMed ID: 2642527
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum.
Chulay JD; Lyon JA; Haynes JD; Meierovics AI; Atkinson CT; Aikawa M
J Immunol; 1987 Oct; 139(8):2768-74. PubMed ID: 3309058
[TBL] [Abstract][Full Text] [Related]
15. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.
Sharma B
In Silico Biol; 2008; 8(3-4):193-206. PubMed ID: 19032156
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
17. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.
Roeffen W; Geeraedts F; Eling W; Beckers P; Wizel B; Kumar N; Lensen T; Sauerwein R
Infect Immun; 1995 Feb; 63(2):467-71. PubMed ID: 7822011
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
[TBL] [Abstract][Full Text] [Related]
19. Target antigens in malaria transmission blocking immunity.
Carter R; Miller LH; Rener J; Kaushal DC; Kumar N; Graves PM; Grotendorst CA; Gwadz RW; French C; Wirth D
Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):201-13. PubMed ID: 6151684
[TBL] [Abstract][Full Text] [Related]
20. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
